Chitosan-based Nanoparticles in Mucosal Vaccine Delivery

Area of Science:

• Immunology
• Nanotechnology
• Vaccinology

Background:

• Infectious diseases often originate from mucosal surfaces, necessitating effective prevention strategies.
• Vaccines are crucial for preventing infectious diseases, immune disorders, and allergies, with adjuvants enhancing immune stimulation.
• Mucosal vaccine delivery offers an alternative route to induce both humoral and cellular immunity.

Purpose of the Study:

• To review recent advancements in chitosan nanoparticles as a novel mucosal vaccine delivery system.
• To explore the immunological activity and mucoadhesive properties of chitosan nanoparticles for vaccine applications.

Main Methods:

• Review of current literature on chitosan nanoparticles in vaccine delivery.
• Analysis of chitosan nanoparticle characteristics, including immunological activity and mucoadhesion.
• Evaluation of chitosan nanoparticles' role in antigen stability, immunogenicity, and targeted delivery.

Main Results:

• Chitosan nanoparticles demonstrate immunological activity and mucoadhesive properties, making them suitable for mucosal delivery.
• Nanoparticle formulation enhances antigen stability and immunogenicity.
• Targeted delivery by nanoparticles leads to more specific release of vaccine antigens.

Conclusions:

• Chitosan nanoparticles represent a promising platform for developing effective mucosal vaccines.
• Their unique properties facilitate improved antigen delivery and immune response induction.
• Further research into chitosan nanoparticles can advance vaccine development for various diseases.